DLGAP5 identified as new prognostic biomarker and therapeutic target for LUAD
March 5, 2024
Scientists from Sun Yat-sen University Cancer Center (SYSUCC) and affiliated organizations have reported data from a study that assessed the role of discs large-associated protein 5 (DLGAP5) in lung adenocarcinoma (LUAD).